Novel insights on HIV/AIDS and cardiac disease: Shedding light on the HAART of Darkness

European Heart Journal

Volumn 33, Issue 7, 2012, Pages 813-815

  Biondi Zoccai, Giuseppe ^a,b   D'Ascenzo, Fabrizio ^b,c   Modena, Maria Grazia ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b Meta analysis and Evidence based Medicine Training in Cardiology (METCARDIO)   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE CORONARY SYNDROME; CARDIOMYOPATHY; CEREBROVASCULAR DISEASE; CORONARY ARTERY DISEASE; EDITORIAL; EPIDEMIC; HEART DISEASE; HEART LEFT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FAILURE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; PATHOGENESIS; PERICARDIAL EFFUSION; PERICARDITIS; PERIPARTUM CARDIOMYOPATHY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; VALVULAR HEART DISEASE;

ACUTE CORONARY SYNDROME; ANTI-HIV AGENTS; FEMALE; HEART DISEASES; HIV INFECTIONS; HUMANS; MALE;

EID: 84859492290     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehr413     Document Type: Editorial

References (12)

1. UNAIDS/WHO report highlights epidemic resurgence. AIDS Alert 2007;22: suppl1-3.
2. Gottlieb MS. Pneumocystis pneumonia - Los Angeles. 1981. Am J Public Health 2006;96:980-981.
3. Barbaro G, Iacobellis G. Metabolic syndrome associated with HIV and highly active antiretroviral therapy. Curr Diab Rep 2009;9:37-42.
4. Guaraldi G. Cardiovascular complications in HIV-infected individuals. Curr Opin HIV AIDS 2006;1:507-513.
5. Ho JE, Hsue PY. Cardiovascular manifestations of HIV infection. Heart 2009;95: 1193-1202.
6. Sliwa K, Carrington MJ, Becker A, Thienemann F, Ntsekhe M, Stewart S. Contribution of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic to de novo presentations of heart disease in the Heart of Soweto Study cohort. Eur Heart J 2012;33:866-874.
7. Pozzan G, Pagliari C, Tuon FF, Takakura CF, Kauffman MR, Duarte MI. Diffuse-regressive alterations and apoptosis of myocytes: possible causes of myocardial dysfunction in HIV-related cardiomyopathy. Int J Cardiol 2009;132: 90-95.
8. Abbate A, Biondi-Zoccai GG, Baldi A. Pathophysiologic role of myocardial apoptosis in post-infarction left ventricular remodeling. J Cell Physiol 2002;193: 145-153.
9. Hulten E, Mitchell J, Scally J, Gibbs B, Villines TC. HIV positivity, protease inhibitor exposure and subclinical atherosclerosis: a systematic review and meta-analysis of observational studies. Heart 2009;95:1826-1835.
10. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007;335:806-808.
11. Lurie P, Wolfe SM. Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries. N Engl J Med 1997;337:853-856. (Pubitemid 27391640)
12. Biondi-Zoccai G, Romagnoli E, Agostoni P, Capodanno D, Castagno D, D'Ascenzo F, Sangiorgi G, Modena MG. Are propensity scores really superior to standard multivariable analysis? Contemp Clin Trials 2011;32:731-740.